Multi-omics approaches to study fatty liver

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055225

Enrollment

Unknown

Registered

2022-01-03

Start date

2021-10-14

Completion date

Unknown

Last updated

2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver

Interventions

NAFLD group:none

Non-NAFLD group:none

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. From August 2021 to September 2022, the medical examination outpatients in our hospital, aged between 18-85 years. 2. NAFLD group: abdominal B-ultrasonography conformed to the diagnostic criteria of diffuse fatty liver. 3. Non-NAFLD group: Abdominal B-ultrasound showed no obvious abnormal echogram of liver.

Exclusion criteria

Exclusion criteria: 1. History of heavy drinking, equivalent to ethanol <140 g/week (women <70 g/week); 2. Viral hepatitis such as hepatitis B or hepatitis C in the past; 3. Ultrasound showed liver enlargement; 4. BMI<16 and incomplete data.

Design outcomes

Primary

Measure	Time frame
Alanine aminotransferase;Aspartate aminotransferase;Blood sugar;Triglycerides;Total cholesterol;High density lipoprotein;Low-density lipoprotein;Insulin determination;	—

Countries

China

Contacts

Public ContactRen Yan

West China Hospital, Sichuan University

renyan922@163.com+86 18980601310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026